X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14001) 14001
Newsletter (51) 51
Magazine Article (29) 29
Newspaper Article (22) 22
Book Chapter (21) 21
Book Review (5) 5
Web Resource (5) 5
Dissertation (4) 4
Conference Proceeding (3) 3
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
infliximab (12270) 12270
humans (11938) 11938
female (6671) 6671
male (6522) 6522
antibodies, monoclonal - therapeutic use (6407) 6407
adult (5313) 5313
middle aged (4812) 4812
tumor necrosis factor-alpha - antagonists & inhibitors (4346) 4346
treatment outcome (4056) 4056
gastroenterology & hepatology (3405) 3405
etanercept (3282) 3282
rheumatology (3155) 3155
adalimumab (3109) 3109
antirheumatic agents - therapeutic use (3047) 3047
therapy (2604) 2604
aged (2473) 2473
arthritis, rheumatoid - drug therapy (2379) 2379
crohn disease - drug therapy (2353) 2353
crohn's disease (2125) 2125
rheumatoid arthritis (2094) 2094
inflammatory-bowel-disease (1942) 1942
crohns-disease (1924) 1924
rheumatoid-arthritis (1863) 1863
antibodies, monoclonal - adverse effects (1837) 1837
efficacy (1701) 1701
anti-inflammatory agents - therapeutic use (1675) 1675
adolescent (1665) 1665
inflammatory bowel disease (1643) 1643
immunosuppressive agents - therapeutic use (1639) 1639
double-blind (1614) 1614
immunoglobulin g - therapeutic use (1565) 1565
receptors, tumor necrosis factor - therapeutic use (1557) 1557
retrospective studies (1524) 1524
severity of illness index (1501) 1501
methotrexate (1496) 1496
gastrointestinal agents - therapeutic use (1491) 1491
young adult (1473) 1473
infliximab - therapeutic use (1465) 1465
ulcerative colitis (1455) 1455
pharmacology & pharmacy (1434) 1434
monoclonal antibodies (1371) 1371
care and treatment (1366) 1366
drug therapy (1255) 1255
drug therapy, combination (1223) 1223
dermatology (1212) 1212
arthritis (1155) 1155
medicine & public health (1141) 1141
safety (1132) 1132
colitis, ulcerative - drug therapy (1131) 1131
psoriasis (1086) 1086
patients (1068) 1068
necrosis-factor-alpha (1067) 1067
follow-up studies (1050) 1050
antibodies, monoclonal, humanized (1032) 1032
disease (1009) 1009
tumor necrosis factor (1005) 1005
antibodies, monoclonal - administration & dosage (983) 983
tumor necrosis factor-α (966) 966
child (964) 964
tumor necrosis factor-tnf (960) 960
antibodies, monoclonal, humanized - therapeutic use (953) 953
antirheumatic agents - adverse effects (932) 932
inflammatory bowel diseases - drug therapy (928) 928
immunology (926) 926
methotrexate - therapeutic use (923) 923
risk factors (902) 902
remission induction (896) 896
time factors (855) 855
prospective studies (846) 846
ulcerative-colitis (839) 839
tumor-necrosis-factor (838) 838
remission (837) 837
psoriasis - drug therapy (829) 829
tumor necrosis factor-alpha - immunology (828) 828
abridged index medicus (817) 817
inflammation (812) 812
medicine, general & internal (805) 805
anti-inflammatory agents, non-steroidal - therapeutic use (793) 793
animals (777) 777
management (774) 774
analysis (755) 755
research (748) 748
azathioprine (697) 697
monoclonal-antibody (690) 690
tnf-alpha (686) 686
health aspects (679) 679
trial (667) 667
adalimumab - therapeutic use (660) 660
maintenance therapy (656) 656
spondylitis, ankylosing - drug therapy (641) 641
surgery (640) 640
crohn disease - complications (633) 633
inflammatory bowel diseases (624) 624
internal medicine (621) 621
antibodies (616) 616
risk (588) 588
biological products - therapeutic use (582) 582
dermatologic agents - therapeutic use (577) 577
ankylosing spondylitis (575) 575
prognosis (571) 571
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13457) 13457
Spanish (197) 197
French (191) 191
German (183) 183
Japanese (134) 134
Portuguese (59) 59
Italian (50) 50
Russian (47) 47
Danish (28) 28
Korean (23) 23
Chinese (22) 22
Hungarian (21) 21
Polish (21) 21
Dutch (18) 18
Hebrew (7) 7
Norwegian (7) 7
Croatian (5) 5
Finnish (5) 5
Turkish (4) 4
Czech (3) 3
Serbian (2) 2
Swedish (2) 2
Greek (1) 1
Lithuanian (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Dermatology, ISSN 0190-9622, 2019, Volume 80, Issue 4, pp. 1029 - 1072
Journal Article
The Medical clinics of North America, ISSN 0025-7125, 05/2012, Volume 96, Issue 3, pp. 475 - 496
Over the past several decades, rheumatology has directed its focus to understanding and countering the immune dysregulation underlying autoimmune diseases with... 
Biologic response modifiers | Systemic lupus erythematosus | Vasculitis | Disease-modifying antirheumatic drugs | Biologics | Rheumatoid arthritis | SYSTEMIC-LUPUS-ERYTHEMATOSUS | RITUXIMAB THERAPY | 5-AMINOSALICYLIC ACID | REFRACTORY NEUROSARCOIDOSIS | ADENOSINE RECEPTORS | MEDICINE, GENERAL & INTERNAL | TUMOR-NECROSIS-FACTOR | COMBINATION TREATMENT | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | MYCOPHENOLATE-MOFETIL | Hydroxychloroquine - therapeutic use | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Certolizumab Pegol | Rheumatic Diseases - drug therapy | Colchicine - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - therapeutic use | Immunoglobulin Fab Fragments - therapeutic use | Methotrexate - therapeutic use | Polyethylene Glycols - therapeutic use | Cyclophosphamide - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Abatacept | Etanercept | Infliximab | Minocycline - therapeutic use | Immunoconjugates - therapeutic use | Antirheumatic Agents - therapeutic use | Rheumatic Diseases - immunology | Sulfasalazine - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Immunoglobulin G - therapeutic use | Rituximab | Cyclosporine - therapeutic use | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Isoxazoles - therapeutic use | Adalimumab | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Tumor Necrosis Factors - antagonists & inhibitors
Journal Article
Seminars in nephrology, ISSN 0270-9295, 2015, Volume 35, Issue 5, pp. 509 - 520
Journal Article
Journal Article
2002, Volume 16, Issue 3, 18
... have led to a variety of evaluable therapeutic approaches in MS. However, in contrast to the successfully introduced and established immunomodulatory therapies (e.g... 
Lenercept, therapeutic use | Monoclonal antibodies, therapeutic use | Tumour necrosis factor antagonists, therapeutic us | Cetermin, therapeutic use | Sulfasalazine, therapeutic use | Cladribine, therapeutic use | Research and development | Interleukin 10, therapeutic use | Infliximab, therapeutic use | Muromonab CD3, therapeutic use | Gusperimus, therapeutic use | Priliximab, therapeutic use | Multiple sclerosis, treatment | Immunoglobulins, therapeutic use | Interleukin 4, therapeutic use | Roquinimex, therapeutic use | AI 100, therapeutic use | Antibodies | Pharmacotherapy | Cancer Research | Molecular Medicine | Biomedicine | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS | ALTERED PEPTIDE LIGAND | SECONDARY PROGRESSIVE MS | T-CELL VACCINATION | IMMUNOLOGY | FACTOR-ALPHA | TUMOR-NECROSIS-FACTOR | GROWTH-FACTOR-BETA | ONCOLOGY | INTRAVENOUS IMMUNOGLOBULIN | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | Antigens, CD - immunology | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - therapeutic use | Multiple Sclerosis - therapy | Antigens - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Treatment Failure | Multiple Sclerosis - immunology | Multiple Sclerosis - pathology | T-Lymphocytes - immunology | Photopheresis | Clinical Trials as Topic - methods | Cytokines - antagonists & inhibitors
Book Review
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2007, Volume 56, Issue 1, pp. 69 - 83
... vulnerable to treatment by targeted therapy. This article reviews both standard and newer therapeutic options for cutaneous sarcoidosis. 
Dermatology | TUMOR-NECROSIS-FACTOR | LOW-DOSE METHOTREXATE | IN-VITRO | GRANULOMA-FORMATION | FACTOR-ALPHA PRODUCTION | LUPUS-PERNIO | TH2 CYTOKINES | PULMONARY SARCOIDOSIS | ALVEOLAR MACROPHAGES | TNF-ALPHA | DERMATOLOGY | Abnormalities, Drug-Induced - prevention & control | Chlorambucil - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Laser Therapy | Antibodies, Monoclonal - therapeutic use | Male | Dermatologic Agents - therapeutic use | Methotrexate - therapeutic use | Skin Diseases - pathology | Adrenal Cortex Hormones - therapeutic use | Th1 Cells - immunology | Pentoxifylline - therapeutic use | Contraindications | Infliximab | Sarcoidosis - immunology | Anti-Inflammatory Agents - therapeutic use | Female | Pentoxifylline - pharmacology | Drug Therapy, Combination | Th1 Cells - drug effects | Sarcoidosis - drug therapy | Skin Diseases - drug therapy | Skin Diseases - immunology | Antimalarials - therapeutic use | Sarcoidosis - etiology | Pregnancy Complications - drug therapy | Pregnancy | Skin Diseases - etiology | Cyclosporine - therapeutic use | Allopurinol - therapeutic use | Models, Immunological | Animals | Melatonin - therapeutic use | Antigen Presentation - drug effects | Cytokines - antagonists & inhibitors | Isoxazoles - therapeutic use | Thalidomide - therapeutic use | Tetracyclines - therapeutic use | Pregnancy Complications - immunology | Sarcoidosis - pathology
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2014, Volume 121, Issue 3, pp. 785 - 796.e3
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2016, Volume 2016, Issue 6, p. CD008334
Journal Article